3P Biopharmaceuticals is a European CDMO specialized in developing and manufacturing biopharmaceutical and cell therapy products from early stages through commercialization. They support process development from batch fermentation to perfusion, as well as analytical development and validation of testing methods in compliance with regulations. 3P Biopharmaceuticals also generates and characterizes cell banks in ISO5-classified clean rooms, and stores raw materials, intermediates, and finished products at controlled temperatures.
1 of 5
Download to read offline
More Related Content
Biopharmaceutical and cell therapy products
1. 3P Biopharmaceuticals
3P Biopharmaceuticals is a European-based Contract Development and Manufacturing
Organization (CDMO) specialized in the process development and GMP manufacture of
biopharmaceutical and cell therapy products from early stages (POC,PC) up to clinical
and commercial.
Development
and Validation
of Analytical
Methods
2. Process Development
Biosynthesis Development
3P Biopharmaceuticals R&D Department
supports development and optimization of
processes offering batch, high cell density
fed-batch fermentation, and perfusion,
including medium and feeding strategy.
Analytical Development
Effective development and qualification
of analytical and bioanalytical methods
for end product testing (API and final
drug product) is developed in compliance
with regulatory requirements.
4. Cellbanks
Generation and characterization of
master/working cell banks
3P Biopharmaceuticals efforts have been
focused on the installation of two separate
rooms for the preparation of ISO5-
classified cell banks with state-of-the-art
biosafety cabinets based on the important
development of the first phases of
biologics.
Cell bank storage
As a fundamental part of the chain of
value of the products manufactured by 3P
Biopharmaceuticals, storage of raw,
intermediate and finished materials at 5 属
C, -20 属 C and -80 尊 C can be
accommodated in control temperature in
real-time.